Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucilla Parnetti

Showing results (11-20 of 283) with videos related to

Pageof 29
Sort By:
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|July 13, 2006
Arterial hypertension and stroke prevention: an updateNatan Bornstein, Giorgio Silvestrelli, Valeria Caso, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|November 27, 2002
Heart-brain relationship: atrial fibrillation and strokeNatan Bornstein, Francesco Corea, Virgilio Galllai, et al.
Journal of Clinical Medicine|February 27, 2020
Lysosomal Ceramide Metabolism Disorders: Implications in Parkinson's DiseaseSilvia Paciotti, Elisabetta Albi, Lucilla Parnetti, et al.
Biomarkers in Medicine|December 9, 2015
Value of cerebrospinal fluid α-synuclein species as biomarker in Parkinson's diagnosis and prognosisLucilla Parnetti, Claudia Cicognola, Paolo Eusebi, et al.
Journal of Alzheimer'S Disease : JAD|April 25, 2017
Biomarkers for Early Diagnosis of Alzheimer's Disease in the Oldest Old: Yes or No?Lucia Paolacci, David Giannandrea, Patrizia Mecocci, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 5, 2016
Cerebrospinal fluid biomarkers in Alzheimer's and Parkinson's diseases-From pathophysiology to clinical practiceKaj Blennow, Leonardo Biscetti, Paolo Eusebi, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 26, 2019
Has the time arrived for cerebrospinal fluid biomarkers in psychiatric disorders?Alberto Lleó, Lucilla Parnetti, Olivia Belbin, et al.
Frontiers in Neurology|June 22, 2018
Are We Ready for Detecting α-Synuclein Prone to Aggregation in Patients? The Case of "Protein-Misfolding Cyclic Amplification" and "Real-Time Quaking-Induced Conversion" as Diagnostic ToolsSilvia Paciotti, Giovanni Bellomo, Leonardo Gatticchi, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 16, 2019
The vicious cycle between α-synuclein aggregation and autophagic-lysosomal dysfunctionGiovanni Bellomo, Silvia Paciotti, Leonardo Gatticchi, et al.
Brain Sciences|August 28, 2019
Biomarker-Based Signature of Alzheimer's Disease in Pre-MCI IndividualsElena Chipi, Nicola Salvadori, Lucia Farotti, et al.
Pageof 29

Showing results (11-20 of 283) with videos related to

Sort By:
Pageof 29
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|July 13, 2006
Arterial hypertension and stroke prevention: an updateNatan Bornstein, Giorgio Silvestrelli, Valeria Caso, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|November 27, 2002
Heart-brain relationship: atrial fibrillation and strokeNatan Bornstein, Francesco Corea, Virgilio Galllai, et al.
Journal of Clinical Medicine|February 27, 2020
Lysosomal Ceramide Metabolism Disorders: Implications in Parkinson's DiseaseSilvia Paciotti, Elisabetta Albi, Lucilla Parnetti, et al.
Biomarkers in Medicine|December 9, 2015
Value of cerebrospinal fluid α-synuclein species as biomarker in Parkinson's diagnosis and prognosisLucilla Parnetti, Claudia Cicognola, Paolo Eusebi, et al.
Journal of Alzheimer'S Disease : JAD|April 25, 2017
Biomarkers for Early Diagnosis of Alzheimer's Disease in the Oldest Old: Yes or No?Lucia Paolacci, David Giannandrea, Patrizia Mecocci, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 5, 2016
Cerebrospinal fluid biomarkers in Alzheimer's and Parkinson's diseases-From pathophysiology to clinical practiceKaj Blennow, Leonardo Biscetti, Paolo Eusebi, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 26, 2019
Has the time arrived for cerebrospinal fluid biomarkers in psychiatric disorders?Alberto Lleó, Lucilla Parnetti, Olivia Belbin, et al.
Frontiers in Neurology|June 22, 2018
Are We Ready for Detecting α-Synuclein Prone to Aggregation in Patients? The Case of "Protein-Misfolding Cyclic Amplification" and "Real-Time Quaking-Induced Conversion" as Diagnostic ToolsSilvia Paciotti, Giovanni Bellomo, Leonardo Gatticchi, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 16, 2019
The vicious cycle between α-synuclein aggregation and autophagic-lysosomal dysfunctionGiovanni Bellomo, Silvia Paciotti, Leonardo Gatticchi, et al.
Brain Sciences|August 28, 2019
Biomarker-Based Signature of Alzheimer's Disease in Pre-MCI IndividualsElena Chipi, Nicola Salvadori, Lucia Farotti, et al.
Pageof 29